We previously reported that the TATA-less rat xanthine dehydrogenase/oxidase (XDH/XO) promoter is organized with multiple initiator elements (Inr 1, 2, 3 and 4). Additionally, we identified six factor binding footprints in the upstream region of this promoter (FP 1-FP 6), two of which (FP 2 and FP 4) we showed to be C/EBP binding sites. In this report we continue our characterization of the XDH/XO promoter, detailing other cis elements which comprise the Inr and upstream binding factors. Interestingly, multiple binding domains for known initiator binding proteins, YY-1 and USF-related factor/ TFII-I, have been identified which potentially play an important role in transcription initiation.
INTRODUCTION
Xanthine dehydrogenase (XDH) serves as the rate-limiting enzyme in purine catabolism (1) . XDH catalyzes oxidation of hypoxanthine to xanthine and subsequently to uric acid, using NAD as an electron acceptor. Under certain pathophysiological conditions, XDH can be converted to xanthine oxidase (XO) either by proteolytic cleavage or by oxidation of sulfhydryl groups (1, 2) . XO utilizes oxygen instead of NAD as the electron acceptor and superoxide radicals are produced. Thus, XO has been thought to play a key role in ischemia-reperfusion injury (3) (4) (5) (6) . Recent regulatory studies have shown that XDH/XO can be up-regulated during cytokine treatment or under hypoxic conditions (7) (8) (9) (10) (11) . This up-regulation has been shown, at least in part, to be a transcriptional process. A detailed analysis of the XDH/XO promoter is therefore important to understand the regulatory mechanism.
Genes subject to RNA polymerase II transcription can be divided into two groups, which differ in the presence or absence of a TATA box located 25-30 bp upstream of the transcription initiation site. Even in the absence of a TATA sequence, a precise transcription initiation site can still be detected. Current observations have shown that the transcription initiation regions (Inrs) of the TATA-less genes are also sequence-specific protein binding sites (12) . However, the relationship between transcription initiation and protein binding to the Inrs is not fully understood. Transcription factors YY-1 and TFII-I seem to be the most prominent Inr binding proteins.
Ying-Yang-1 (YY-1) is a 45 kDa zinc finger protein, although it migrates with an apparent molecular weight of 65 kDa in SDS-polyacrylamide gels (13) . A consensus binding sequence 5′-C / G GCCAT T / C TTG-3′ has been deduced for YY-1 (13) . The initiator regions of the adeno-associated virus (AAV) P5 promoter (14) and the mouse ribosomal protein rpL30 and rpL32 gene promoters (15) have been shown to bind YY-1. A 17 bp fragment from the mouse TdT initiator, which includes a putative YY-1 binding site, has been shown to be sufficient for transcription initiation.
The isolation of TFII-I was first described by Roy et al. in 1991 (16) . TFII-I itself can bind both as a monomer and as a dimer to two motifs, the adenovirus major late promoter (AdML) initiator (5′-CTCACTCTCT-3′) or to an E box motif (5′-GCCACGT-GAC-3′), which have no obvious sequence similarity. TFII-I has also been shown to interact with the TFII-D complex (17) . TFII-I can substitute for TFII-A to allow stable formation of a pre-initiation complex in a TATA-independent manner. Roy et al. proposed a TFII-I-dependent pathway for the formation of a pre-initiation complex on a TATA-less promoter.
Our previous studies have shown that the rat XDH/XO gene is a TATA-less gene. Four Inrs have been found just upstream of the translational start (ATG). Each of these four sites meet the criteria for identification as an initiator: (i) the sequence should direct transcription initiation from a TATA-less promoter in vivo; (ii) the sequence should match canonical sequences identified from welldocumented initiators; (iii) transcription should be orientation dependent; (iv) transcriptional activity from the initiator can be stimulated by a general transcription factor. In addition, two C/EBP binding sites were identified among the six footprints found upstream of the Inrs. Thus, unlike most of the TATA-less genes that are activated by a GC-rich region (Sp-1), XDH/XO is an atypical TATA-less gene with C/EBP factors activating the downstream multiple initiators.
In this report, we demonstrate that there are multiple binding domains for YY-1 and USF-related factors in the rat XDH/XO TATA-less promoter. We surmise that the USF-related factor is TFII-I. Based upon sequence similarities, we have deduced a *To whom correspondence should be addressed. Tel: +1 615 323 4611; Fax: +1 615 322 7236; Email: roger.chalkley@mcmail.vanderbilt.edu 5) and a consensus Oct-1 oligonucleotide (lanes 6-10) as probes. Lanes 1 and 6, no competitor; lanes 2 and 3, 10-and 100-fold molar excess of consensus Oct-1 oligonucleotide as competitor; lanes 4, 5 and 9, 10-, 10-and 100-fold molar excess of HS B oligonucleotide as competitor. Lanes 7 and 8, 10-and 100-fold molar excess of FP 5 oligonucleotide as competitor.
consensus sequence (5′-YYYY T / A CAAN T / G T / G G / C Y-3′) for USF-related factor/TFII-I binding. In addition, NF-1 and Oct-1 can bind upstream of the promoter.
MATERIALS AND METHODS

Gel mobility shift assay
Procotols for preparing rat liver nuclei extract and for performing gel shift assays have been described previously (18) . For gel shift assays with antibody, protein-DNA complexes were allowed to form in the presence of binding buffer and poly(dI·dC) before adding antibody.
For double competition assays, a 100-fold excess of competitors were incubated with a binding mix [10 mM HEPES, pH 7.9, 50 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1.4 mM β-mercaptoethanol, 10% glycerol and 4 µg poly(dI·dC), competitors and probe] and nuclei extract for 30 min at room temperature before adding antibody. After another 30 min incubation at room temperature with the antibody, a sample was loaded onto a 6% non-denaturing acrylamide gel and run at 200 V for 90 min at room temperature with 1× TGE buffer. If two different antibodies were used, the first antibody was incubated as mentioned above. After the incubation, the second antibody was added to the mixture and incubated for another 30 min before loading. Oligonucleotides used in this report were synthesized on a Milligen/Biosearch 7500 DNA synthesizer. Sequences for the oligonucleotides used were: Inr 3 (FP 1), 5′-CCGGGAGGCGTATCTTTCAAGTTGCAGG-GCAGT-3′; Inr 4, 5′-ACCGGGTAACTTTGTTTCATTTTGC-TGGGAGG-3′; FP 3, 5′-AAACCTGTGACTCTTGCCAAGA-ACCGTCCATGCCTGGAG-3′; FP 5, 5′-GCAGAGTCGGATT-TGCCTGGTGGCTGTCC-3′; FP 6, 5′-GGGCCTCCCTAATC-TAAGCCTGTGCACTTTGACTAGGAGG-3′; AdML, 5′-TCG-GTCCTCACTCTCTTCCGGG-3′; EF II, 5′-TCGAGATCTAAT-GTAGTCTTATGCAATACTCTTGTAGTCTTGCAACACCC-3′; DHFR, 5′-GGCTGCGATTTCGCGCCAAACTTGACGGCA-3′; PBGD, 5′-TCAGTGTCCTGGTTACT-3′; TdT, 5′-GACATCA-GAGCCCTCATTCTGGAGACACCACCTGA-3′; YY-1, 5′-CG-CTCCGCGGCCATCTTGGCGGCTGGT-3′; NF-1, 5′-TTTTG-GATTGAAGCCAATATGATAA-3′; MLTF, 5′-TCGAGCCAC-GTGACGATC-3′; Oct-1, 5′-GCAGAGTAGGATTTGCCTGG-TGGCTGTCC-3′.
RESULTS
Our recent report on the rat XDH/XO gene promoter indicated that there are four Inrs as well as six factor binding footprints (FP 1-FP 6) present in the upstream region of the promoter. The accompanying report shows that much of the contribution to the overall transcriptional activity of the promoter comes from cis elements which make up the Inrs and the upstream binding factors. Two of the footprints (FP 2 and FP 4) have been previously shown to be C/EBP binding sites (19) .
Transcription factor NF-1 binds to FP 3 and transcription factor Oct-1 binds to FP 5 of the XDH/XO promoter Visual inspection of the sequence encompassed by FP 3 suggested that the binding factor might be transcription factor NF-1 (20; Fig. 1A ). To test this idea, an oligonucleotide containing the FP 3 sequence was synthesized and used in gel mobility shift assays. As shown in Figure 1A , using radiolabeled FP 5 is located between -176 and -204 bp upstream of the XDH/XO translational start site. Sequence analysis indicated that an Oct-1 binding site might be present in this region (20) . An oligonucleotide encompassing the FP 5 region was synthesized and used as a probe in gel mobility shift assays. As shown in Figure 1B , protein-DNA complexes generated by the FP 5 oligonucleotide are similar to the complexes formed by an Oct-1 consensus oligonucleotide. Furthermore, complexes formed by the Oct-1 consensus oligonucleotide can be effectively competed by FP 5. Hypersensitive site B (HS B) from the rat phosphoenolpyruvate carboxykinase (PEPCK) gene promoter, which has been shown to bind Oct-1 (S.Kupershmidt, personal communication), competes against both the Oct-1 consensus and FP 5 oligonucleotides. However, the Oct-1 consensus oligonucleotide does not compete against FP 5. We surmise that FP 5 binds an Oct-1-related factor. This Oct-1-related factor is presumably closely related to the factor which binds to the HS B oligonucleotide and is more distantly related to the known Oct-1 factor.
Besides C/EBP binding factors, transcription factor YY-1 also binds to FP 2 of the XDH/XO promoter
Our previous report showed that both FP 2 and FP 4 of the rat XDH/XO promoter bind C/EBP factors (primarily C/EBP β) (19) . However, FP 2 is larger than FP 4. In FP 4, the consensus C/EBP binding site (P2-C/EBP, TTGTGCAAA) is located symmetrically in the center of the footprint (see Fig. 4C; 19 ). In the larger FP 2, however, the consensus C/EBP binding site (P1-C/EBP, TTGGGTAAC) is skewed toward the upstream region, suggesting that there might be an additional binding site present in the downstream region of FP 2. Interestingly, this downstream region maps to the same location as one of the transcription initiation sites (Inr 4). An oligonucleotide encompassing this downstream region was synthesized and used in gel mobility shift assays. As shown in Figure 2A , using the entire region of FP 2 as probe, multiple complexes are observed and most of these complexes can be competed by a 100-fold molar excess of EF II oligonucleotide (a known strong C/EBP β binding site; 18). However, a residual protein-DNA complex is observed after EF II competition which can be competed by the Inr 4 oligonucleotide. No such complex is observed when the smaller FP 4 is competed in a similar fashion (data not shown). Thus, we conclude that in addition to C/EBP β, there is an additional factor binding to the Inr 4 region of FP 2.
We have pursued the nature of this factor using an Inr 4 oligonucleotide as probe in gel mobility shift assays. As shown in Figure 2B , multiple protein-DNA complexes are generated, including several minor complexes (complexes m) located in the upper portion of the gel and two major complexes (M1 and NS). None of these complexes are competed by the EF II oligonucleotide (data not shown), indicating that the C/EBP family is not contributing to these shifts. The NS complex was found to be non-specific and it can be competed by any single-stranded oligonucleotide (data not shown).
To study the nature of these complexes, we have chosen several other initiators as competitors, including initiators from AdML (21), the mouse dihydrofolate reductase gene promoter (DHFR) (22) , the human porphobilinogen deaminase gene promoter (PBGD) (23) and the mouse terminal deoxynucleotidyl transferase gene promoter (TdT) (24) . The AdML and PBGD initiators do not affect formation of these protein-DNA complexes (Fig. 2B) . However, the DHFR and TdT initiators competed against the upper, minor complexes. In addition, the TdT initiator competed somewhat within the M1 complex. Since YY-1 has been shown to be a protein binding within the TdT initiator (14) and since there is a near canonical YY-1 binding site within the Inr 4 sequence, we also used a YY-1 consensus oligonucleotide as competitor. The M1 complex consists of two components and the major component can be competed effectively by the YY-1 oligonucleotide, which is shown more clearly by a longer separation of the M1 complex, as shown in Figure 2B . However, YY-1 oligonucleotide does not affect the upper, minor complexes. Interestingly, the upper, minor complexes can be competed by Inr 3 oligonucleotide.
To confirm that transcription factor YY-1 binds to Inr 4, we have utilized a specific antibody against YY-1 in gel mobility shift assays. As shown in Figure 2C , formation of M1 complex is diminished and a supershift is observed only in the presence of YY-1 antibodies. No such effect is observed when antibodies against Myc, E2F or E12 are used.
We conclude that both YY-1 and C/EBP factors can bind to FP 2. Interestingly, the YY-1 binding site within FP 2 also resides within the Inr 4 region of the rat XDH/XO promoter. Confirmation of the identification of the YY-1 site comes from an Inr 4 mutant in which a critical thymine residue was mutated to adenine, with loss of YY-1 binding (data not shown). It is of interest that the TdT YY-1 binding site deviates slightly from the canonical sequence in exactly the same way as the Inr 4 site, though this is unlikely to be a general requirement for initiation, as the E1 initiator more precisely reflects the canonical sequence (25) .
Inr 3 (FP 1) binds a transcriptional factor that is related to USF
Inspection of the sequence encompassed by FP 1 revealed no obvious sequence homology to known factor binding sites, however, there is a positional match for 14 out of 19 nt between FP 1 and FP 2. In both cases this match includes the Inr 3 and Inr 4 sequences. Accordingly, in an initial experiment we compared the factors binding to these regions. The results are shown in Figure 3 . Clearly, these two sequences bind different factors, as evidenced by different mobilities and a failure to cross-compete. Only in the case of several minor bands, denoted 'complexes m', was there any cross-competition. The YY-1 complex characteristic of the Inr 4 oligonucleotide is absent from the Inr 3 oligonucleotide. We have further pursued the identity of complexes binding to the Inr 3 (FP 1) oligonucleotide by competition assays with known initiator sequences. The results are shown in Figure 4A . The initiator sequence derived from the DHFR gene competes strongly against complexes B and C formed by the Inr 3 oligonucleotide. Paradoxically, complex A is increased in intensity after such competition. Complexes B and C can also be competed very slightly by the YY-1 and TdT oligonucleotides. An oligonucleotide containing the Inr region of AdML and an oligonucleotide (MLTF) encompassing the E box motif (USF binding site; 26) do not affect complex B formation.
Farnham et al. have reported that transcription factor E2F binds to the initiator sequence of the mouse DHFR gene (22, 27) . We tested if transcription factor E2F binds to Inr 3, although the consensus sequence for E2F binding was not found within the proximal region of Inr 3. As shown in Figure 4B , antibody against E2F does not affect any of the complexes of the Inr 3 gel shifts. In addition, although a YY-1 oligonucleotide competes slightly against complex B, antibodies against YY-1 do not have any effect on the complexes (data not shown). In addition, the YY-1 complex formed in Inr 4 migrates to a different position compared with the complexes formed in Inr 3. These results suggest that complex B is different from the YY-1 complex present in Inr 4.
During this study antibody against TFII-I was not readily available. However, Roy et al. have reported that antibodies against Figure 4B , USF antibodies disrupt complex B formation in Inr 3 gel shifts. Also, in a manner similar to competition with the DHFR oligonucleotide, formation of complex A is increased by anti-USF antibody treatment. In addition, following treatment with antibodies another complex (complex C) was also increased in intensity. To test the hypothesis that a USF-related protein (e.g. TFII-I), instead of authentic USF (which is known to be stable to heat treatment; 26), is binding to Inr 3, a heat-treated nuclear extract was used. As shown in Figure 4C , complex B is highly sensitive to heat; exposure to 70_C for as little as 2 min inhibited complex B formation. Using MLTF, an E box motif that binds authentic USF, as probe, complexes are formed even with the heat-treated nuclear extract, indicating, as expected, that USF is heat stable. Also, the complexes formed by the two probes are clearly different in mobility. In addition, when MLTF was used as probe in the presence of anti-USF antibody, instead of disrupting the protein-DNA complex as observed in complex B of the Inr 3 gel shifts, a supershift was observed (data not shown). Taken together, we conclude: (i) that a USF-related protein (definitely not USF itself and very likely TFII-I) binds to Inr 3; (ii) that complex B is made up of the USF-like protein together with an unknown factor and that this interaction is not maintained in the presence of anti-USF antibody, so that only the result of DNA interacting with the unknown protein (complex C) is detected in the presence of the antibody.
USF can cross-react with TFII-I (16). As shown in
Myc binds to Inr 3 to form complex A
As mentioned above, treatment of the Inr 3 complexes with DHFR oligonucleotides or anti-USF antibodies generates a paradoxical increase in the amount of complex A. Based on the position of migration in the gel and recent reports of a key role for Myc in regulation of Inr activity, we have attempted to test if Myc binds to Inr 3 oligonucleotides (17, 28, 29) . Preliminary experiments indicated that Myc antibodies can disrupt formation of complex A. These experiments were repeated in the presence of competitor DHFR oligonucleotide, as this increases the amount of complex A. As shown in Figure 5A , in the presence of monoclonal antibodies against the C-terminal portion of c-Myc protein or polyclonal antibodies against full-length c-Myc protein, formation of complex A is disrupted. Disruption of complex A by the C-terminal antibodies can be prevented if the corresponding antigen was used to pre-treat the antibodies (data not shown). Antibodies against the N-terminal portion of c-Myc protein can also disrupt formation of complex A slightly. However, antibodies against Max, a possible partner of Myc, do not affect formation of complex A.
As previously shown in Figure 4B , antibodies against USF also increase formation of complex A. In Figure 5B , a similar double competition experiment using the anti-USF antibodies, instead of the DHFR oligonucleotides, was performed. Again, Myc antibodies disrupted formation of complex A effectively, whereas antibodies against Max, E12 and E2F had no effect. In addition, another complex (complex C) whose formation is also increased during the anti-USF antibody treatment was not affected. Thus, these results suggest that Myc also binds to Inr 3 (FP 1) of the rat XDH/XO gene promoter.
This result was particularly intriguing as there is no consensus E box (the canonical Myc-binding site) in the Inr 3 sequence used in these experiments.
FP 6 and Inr 3 (FP 1) bind similar factors
Initial gel mobility shift assays utilizing an oligonucleotide encompassing FP 6 indicated that bound factors showed a mobility pattern similar to that seen for Inr 3 (FP 1). Accordingly, a competition experiment between FP 6 and Inr 3 was performed. As shown in Figure 6A , Inr 3 effectively competes against FP 6. In addition, DHFR also competes strongly against a similar complex B in FP 6 with a concomitant increase in formation of a slower migrating complex A. Inr 4, TdT and YY-1 oligonucleotides compete slightly, whereas PBGD, MLTF and AdML oligonucleotides do not affect any complexes. All of these competitions closely reflect the behavior of Inr 3 as described above.
Subsequent gel mobility shift assays in the presence of various antibodies were performed to confirm the similarities between FP 6 and Inr 3. As shown in Figure 6B , anti-USF antibodies disrupt complex B in FP 6 with an increase in formation of complexes A and C. Anti-Myc antibodies, on the other hand, block complex A formation. Antibodies against Max, E12 and E2F do not affect any complexes formed by the FP 6 oligonucleotide. These results again strongly suggest that FP 6 and Inr 3 bind very similar factors, including a USF-related transcription factor/TFII-I, Myc and an unknown factor.
A USF-related factor/TFII-I also binds to Inr 2
As described above, FP 1 and FP 2 bind known initiator binding proteins. Interestingly, Inr 3 and Inr 4 reside within FP 1 and FP 2 respectively. FP 1 binds a USF-related factor, which is likely to be TFII-I, whereas FP 2 binds YY-1. We surmised that similar initiator binding proteins might be present in the Inr 1 and/or Inr 2 regions. Using an oligonucleotide encompassing the Inr 2 region as probe in gel mobility shift assays, a protein-DNA complex can be detected (Fig. 7A) . A 100-fold molar excess of Inr 3 oligonucleotide competed against this complex effectively. Similar results were obtained in the presence of excess FP 6 and DHFR oligonucleotides, which have been previously shown to bind a USF-related factor/ TFII-I. Inr 4, TdT and YY-1 oligonucleotides slightly affect complex formation. However, PBGD and AdML initiator oligonucleotides do not affect complex formation at all. In addition, a USF binding site derived from an E box motif located upstream of the AdML (MLTF) also does not affect the complex.
To test if the complex formed in Inr 2 can be immunologically cross-reacted with USF, as shown previously for Inr 3, a range of specific antibodies was administered. As shown in Figure 7B , anti-USF antibodies can effectively abolish formation of the protein-DNA complex. On the other hand, antibodies against Myc, Max, E12 and E2F do not affect binding. As discussed above, we surmise that this USF-related factor is likely to be TFII-I.
Inr 1 binds similar factors as Inr 3 (FP 1) and FP 6
Using an oligonucleotide encompassing the Inr 1 region as probe in gel mobility shift assays, multiple protein-DNA complexes could be detected (Figure 8) . Inspection of the Inr 1 sequence suggested that TFII-I might be interacting with this DNA and this was confirmed using competition with Inr 2 as well as antibodies against USF. In addition, antibodies against C/EBP revealed that this factor (primarily, but not exclusively C/EBP α) is also a major component of the material binding to this region.
DISCUSSION
In this report we have extended our studies on characterization of the rat XDH/XO TATA-less promoter. Besides the two C/EBP β binding sites that we identified previously, we have demonstrated that other factors, including NF-1, Oct-1, YY-1, c-Myc and USF-related factors can bind to the upstream region of the rat XDH/XO promoter. A summary representation of the transcription factors which bind to the XDH/XO promoter is shown in Figure 9 . Interestingly, some of these factors, such as YY-1, have been shown to be initiator binding proteins and their positions on the rat XDH/XO promoter reside in the multiple initiators (Inr 1, 2, 3 and 4) of the gene.
Our gel shift analyses have indicated that Inr 1, Inr 2, Inr 3 (FP 1) and FP 6 each form a complex (complex B) that reacts with anti-USF antibodies. Subsequent heat treatment of the nuclear extract has indicated that this factor is not the authentic USF transcription factor (Fig. 4C) . Roy et al. have shown that a factor named TFII-I can also be recognized by anti-USF antibodies (17) . In addition, their studies have shown that TFII-I can bind both the initiator element and an E box motif. Recently, we have learned that an antibody against TFII-I can also cross-react with USF, suggesting that there is a common epitope (R.Roeder, personal communication). Since the binding sites for the USF-related factor on the rat XDH/XO gene are also transcription initiation sites, we surmise that a component of complex B of Inr 2, Inr 3 and FP 6 is highly likely to be TFII-I, or a closely related factor.
Sequence comparison indicates that a 5′-YYYY T / A CAA-N T / G T / G G / C Y-3′ motif may be the consensus sequence necessary for complex B formation between Inr 1, Inr 2, Inr 3 and FP 6 oligonucleotides. A similar motif is also found in the DHFR oligonucleotide, which has been shown to abolish complex B formation when competed with the above four oligonucleotides. We surmise that this 5′-YYYY T / A CAAN T / G T / G G / C Y-3′ sequence may represent a conserved motif for USF-related factor/TFII-I binding. This motif is enriched in pyrimidines and is similar to the consensus initiator motif (5′-YYA +1 N T / A YY-3′) described by Javahery et al. (12 22, 27) . This is not surprising, as the radiolabeled DHFR Inr binds a different set of factors compared with the Inr 3 probe (unpublished results). Although these factors are not competed by the Inr 3 oligonucleotide, the DHFR oligonucleotide can clearly compete for binding to Inr 3. We surmise that besides E2F, DHFR oligonucleotide also binds an additional set of factors that may include USF-related factor/TFII-I.
We have also presented evidence that the FP 6 region binds similar initiator binding proteins as those binding to Inr 3. Our initial efforts on characterization of the rat XDH/XO promoter emphasized the proximal region of the promoter. Subsequently, we have re-analyzed our initial results from the in vivo primer extension and found a longer transcript that is initiated from the 3′-end of FP 6 (unpublished results). Based on the amount of exposure on an X-ray film, the level of initiation from FP 6 is comparable with Inr 3. Interestingly, the 3′-end of FP 6 has sequence similarity to Inr 2 and Inr 3 described above. These observations indicate that FP 6 is also likely to be a functional Inr and can therefore assist assembly of a transcription initiation complex.
In this paper we have shown that at least five separate sites (Inr 1, Inr 2, Inr 3, Inr 4 and FP 6) have been identified as interacting with known initiator binding proteins (YY-1, Myc and USF-related factor/TFII-I). In addition, we have previously shown that YY-1 can also bind to the ATG region of the rat XDH/XO promoter. Altogether, there are five sites [two YY-1 binding sites (Inr 4 and the ATG region) and three USF-related factor/TFII-I binding sites (Inr 1, Inr 2 and Inr 3)] localized within the multiple transcription initiation sites that we identified previously. Although there is no TATA element upstream of the ATG in the XDH/XO gene promoter, the presence of multiple initiator protein binding sites may serve to tether TFII-D complex and/or potentiate the local concentration of TFII-D. This may be important, as the TFII-D complex is easier to dissociate from the promoter in the absence of an upstream TATA element (30) . Interestingly, the three USF-related factor/TFII-I binding sites are flanked by the two YY-1 binding sites. YY-1 has been shown to modulate transcription by affecting DNA topology. It is tempting to speculate that a bent DNA structure may further help to keep TFII-D complex around the XDH/XO promoter.
The finding of multiple binding sites for initiator proteins in a TATA-less gene is not unusual and in fact is probably the norm. However, most of the studies on TATA-less promoters have focused on the major Inr and ignored the less frequently utilized Inrs. We have shown that the multiple Inrs in the XDH/XO promoter can be studied separately. Each Inr has been shown to bind typical initiator binding proteins, such as YY-1 or TFII-I, which presumably play an important role in transcription initiation.
